The global clinical trial supply and logistics market continues to grow, to support increasing pharma R&D spend. With this growth comes the continued drive to reduce cost in the supply chain, in a context in which logistics is becoming more complex due to product sourcing requirements, temperature control, local regulatory requirements and decentralized trial set up.
What if the focus turned from logistics and manufacturing costs, towards optimizing trial duties and VAT to recoup clinical trial services spend?
Join our webinar to learn more as we discuss cost optimization strategies and for practical advice including:
- How VAT and duties appear in the budgets of clinical trials
- What is claimable/non-reclaimable per country
- Duty and VAT per country
- Bottlenecks, and how to resolve them
- Cost reduction case studies
Denis Volkov, Sales Director, Oximio
Denis Volkov leads the global sales team at Oximio (previously SMO Group), which includes partnering with strategic accounts to develop customized solutions to maximize the efficiency and effectiveness of their supply chains. He has extensive experience in the field of clinical trials, including end-to-end regulatory, financial, commercial, legal and compliance activity to ensure that patients receive the right product, at the right time.
Who Should Attend?
- Supply chain and logistics leaders (Heads, VPs, Directors) involved in single, or multi-country trials in Eastern Europe
- Depot and distribution managers
- Supply planners
- GMP manufacturers
What You Will Learn
- Principles of IMP valuation
- Recent updates on customs taxation in Eastern Europe
- Who, where and how to reclaim customs VAT
- Five cost optimization strategies for duties and VAT
Oximio is a clinical trial services provider contributing to research to find effective treatment and cures for all living beings, globally. Oximio works hard to convert the ever-changing face of investigational medical products into new medicines, bringing over 16 years of service excellence to the clinical trial industry. The company provides a direct connection to several patient communities of over 500 million people by being present in the United Kingdom, Eastern Europe, Western Asia and South Africa. Oximio’s large and loyal client base ranges from start-ups to major international organizations, pharmaceutical and R&D companies. Oximio is in the front line of servicing clinical trials with its own warehouses and, through licensed partner sites, offers an end-to-end cold-chain control system in all premises. By combining its ‘best-in-class’ depot network with a highly experienced and qualified workforce, Oximio is thoroughly conversant with both global and local procedures for clinical trials, ensuring the highest standards of operation. Oximio has the following capabilities: supply planning and consulting, comparator sourcing, patient centricity, advanced therapy solutions, import & export regulations, relabelling, warehousing, distribution and courier services, return & destruction.